IL-6001 |
TRIMIPRAMINE |
SURMONTIL |
7162-RP |
TRIMEPROPRIMINE |
7162 RP |
SAPILENT |
TRIMEPRIMINE |
RP-7162 |
5-(GAMMA-DIMETHYLAMINO-BETA-METHYLPROPYL)-10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPINE |
5-[3-(DIMETHYLAMINO)-2-METHYLPROPYL]-10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE |
10,11-DIHYDRO-N,N,BETA-TRIMETHYL-5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE |
BETA-METHYLIMIPRAMINE |
SURMONTIL® |
chemidplus:739-71-9 |
rxcui:10834 |
drugbank:00726 |
chembl:CHEMBL644 |
pubchem.compound:5584 |
Drug Categories | psychoanaleptics |
Drug Categories | non-selective monoamine reuptake inhibitors |
Drug Class | antidepressive agents, tricyclic |
Year of Approval | 1979 |
FDA Approval | 1979 |
Drug Class | small molecule |
Drug Indications | Antidepressive Agents, Tricyclic |
Drug Categories | adrenergic alpha-1 receptor antagonists |
Drug Categories | adrenergic alpha-antagonists |
Drug Categories | adrenergic antagonists |
Drug Categories | agents that produce hypertension |
Drug Categories | agents that reduce seizure threshold |
Drug Categories | combined inhibitors of serotonin/norepinephrine reuptake |
Drug Categories | cytochrome p-450 cyp2b6 substrates |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | histamine antagonists |
Drug Categories | histamine h1 antagonists |
Drug Categories | neurotoxic agents |
Drug Categories | p-glycoprotein substrates |
Drug Categories | potential qtc-prolonging agents |
Drug Categories | qtc prolonging agents |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin 5-ht1 receptor antagonists |
Drug Categories | serotonin 5-ht2 receptor antagonists |
Drug Categories | serotonin agents |
Drug Categories | serotonin receptor antagonists |
Drug Categories | tertiary amine tricyclic antidepressants |
Drug Categories | tricyclics and other norepinephrine-reuptake inhibitors |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | True |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
Specific Action of the Ligand | Inhibition |
n/a |
inhibitor (inhibitory) |
Direct Interaction? | True |
Endogenous Drug? | False |
Specific Action of the Ligand | Inhibition |
739-71-9 | CAS Number |
Apo-trimipramine | Drug Brand |
Herphonal | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | adrenergic agents |
Drug Indications | Antidepressive Agents, Tricyclic |
Drug Class | small molecule |
FDA Approval | 1979 |
Year of Approval | 1979 |
Drug Class | antidepressive agents, tricyclic |
CHEMBL644 | ChEMBL Drug ID |
D00HZV | TTD Drug ID |